Loading...
The URL can be used to link to this page
Your browser does not support the video tag.
Home
My WebLink
About
1.12.23 Board Correspondence - FW_ Report 51_ Liver Adverse Events – Five Deaths Within 20 Days of Pfizer’s mRNA COVID Injection. 50% of Adverse Even…
.ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening attachments, clicking on links, or replying.. From:Clerk of the Board To:Nuzum, Danielle; Reaster, Kayla; Boatwright, JP Subject:Board Correspondence - FW: Report 51: Liver Adverse Events – Five Deaths Within 20 Days of Pfizer’s mRNA COVID Injection. 50% of Adverse Even… Date:Thursday, January 12, 2023 4:40:16 PM Shaina Paulsen Associate Clerk of The Board Butte County Administration 25 County Center Drive, Suite 200, Oroville, CA 95965 T: 530.552.3304 | F: 530.538.7120 From: lance dreiss <lancedreiss@att.net> Sent: Thursday, January 12, 2023 1:16 PM To: Clerk of the Board <clerkoftheboard@buttecounty.net>; York, Danette <DYork@buttecounty.net>; Durfee, Peter <PDurfee@buttecounty.net>; District Attorney <District_Attorney@buttecounty.net>; Lucero, Debra <DLucero@buttecounty.net>; Teeter, Doug <DTeeter@buttecounty.net>; JULIE THREET <prayinghawk144@gmail.com>; Waugh, Melanie <mwaugh@buttecounty.net>; Ritter, Tami <TRitter@buttecounty.net>; Kimmelshue, Tod <TKimmelshue@buttecounty.net>; Pickett, Andy <APickett@buttecounty.net>; Connelly, Bill <BConnelly@buttecounty.net>; Ring, Brian <bring@buttecounty.net>; Stephens, Brad J. <BStephens@buttecounty.net>; Durfee, Peter <PDurfee@buttecounty.net> Subject: Fwd: Report 51: Liver Adverse Events – Five Deaths Within 20 Days of Pfizer’s mRNA COVID Injection. 50% of Adverse Even… The adverse events keep piling up. Cease and desist these harmful and sometimes deadly inoculations in Butte County andtruthfully inform the public. From: "Behind the FDA Curtain: War Room/DailyClout Pfizer Reports" <behindthefdacurtain@substack.com>Date: January 12, 2023 at 12:29:02 PM PSTTo: lancedreiss@att.netSubject: Report 51: Liver Adverse Events – Five Deaths Within 20 Days of Pfizer’s mRNA COVID Injection.50% of Adverse Even…Reply-To: "Behind the FDA Curtain: War Room/DailyClout Pfizer Reports"<reply+1lcm3c&kcryl&&f0ca53406605c4fd9f82559ab7963594ad88f6f89b1729e17dd648dfafdb7bfa@mg1.substack.com> Pfizer used different data collection and reporting methods for the hepatic System Organ Class (SOC) vs. other SOCs - seemingly in order to underestimate liver-related adverse events. Open in app or onlineReport 51: Liver Adverse Events – Five DeathsWithin 20 Days of Pfizer’s mRNA COVID Injection.50% of Adverse Events Occurred Within ThreeDays. Pfizer used different data collection and reporting methods for the hepatic System Organ Class(SOC) vs. other SOCs - seemingly in order to underestimate liver-related adverse events. JAN 12 SAVE ▷ LISTEN As Originally Published on DailyClout. The War Room/DailyClout Pfizer Analysis Post-Marketing Group – Team 1 created the following Liver (i.e., Hepatic) System Organ Class (SOC) Review from data in Pfizer document 5.3.6 Cumulative Analysis of Post- Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). There were 70 patient cases with 94 adverse events reported in the hepatic SOC category. The report shows that five deaths, unexplained by the broad adverse event (AE) descriptions, occurred within 20 days of injection, which suggests severe and rapid liver injury or failure. Also, 50% of adverse events occurred within three days of receiving Pfizer’s mRNA COVID drug. At the data collection cutoff date of February 28, 2021, more than half of the outcomes were unknown and remain unknown to this day. This report is unique compared to other SOC category reports, because the data published by Pfizer largely consist of lab test abnormalities related to liver enzymes rather than clinical disease descriptions. No further categorization or classification under medically recognized diseases, such as hepatitis or hepatobiliary (gallbladder or bile duct) conditions, was done, though the lab tests cited often point to disease entities. Additionally, no justification is offered to explain this inconsistency in Pfizer’s data collection and reporting. Shockingly, for liver adverse events, Pfizer deviated from listing every adverse event, as it had for strokes and cardiovascular abnormalities, and set a threshold of three separate occurrences of an adverse event before the AE became “reportable.” Therefore, when a liver abnormality occurred only once or twice during Pfizer’s post- marketing analysis time frame, it did not reach the threshold of “reportability.” Why was a threshold of “three or more” used before Pfizer would list liver-specific diagnoses? What is potentially hidden in those diagnoses conveniently not reported because they did not reach that arbitrary threshold? One can only conclude that Pfizer deliberately underestimated the number of adverse events in its 5.3.6 document, which it knew would have to be submitted to the Food and Drug Administration (FDA) for safety signal monitoring. It is important to note that the adverse events in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product. Please read this important report below. Please Support DailyClout! Become a DailyClout Member. Share Share Behind the FDA Curtain: War Room/DailyClout Pfizer Reports Upgrade to paid You’re a free subscriber to Behind the FDA Curtain: War Room/DailyClout Pfizer Reports. For the full experience, become a paying subscriber. Upgrade to paid LIKE COMMENT SHARE Read Behind the FDA Curtain: War Room/DailyClout Pfizer Reports in the app Listen to posts, join subscriber chats, and never miss an update from Amy Kelly. © 2023 DailyCloutPO Box 24, Millerton, NY 12546 Unsubscribe